Skip to main content

Activate/Inactivate autoexecution task

The autoexecution tasks added to CTMS to trigger for a certain event—monitoring visit creation or KRI email notification—must be active to start executing as configured. You can use activation and inactivation functionality to temporarily halt or reinstate the task triggering according to your business needs.

To activate or inactivate an autoexecution task

  1. Access the study management page in one of the following ways:

    • In the CTMS application header, select the DASHBOARD tab and then select the study dashboard of your interest.

      Accessing study management from dashboard
      Figure 1. Accessing study management from dashboard

    • In the CTMS application header, select the STUDY MANAGEMENT tab. Then from the Study Data List table, select the study name of your interest.

      Accessing study management from study data list
      Figure 2. Accessing study management from study data list

  2. From the left pane of the study page that opens, select RBM > Auto-execution Engine.

    Accessing autoexecution engine
    Figure 3. Accessing autoexecution engine

  3. In the Auto-execution Task List table that appears, select Inactivate inactivate_icon.png next to the autoexecution task in order to deactivate it. Or select Activate activate_icon.png next to the inactive autoexecution task in order to activate it.

    Activating and inactivating autoexecution task
    Figure 4. Activating and inactivating autoexecution task

  4. If you are inactivating the active task, then in the Reason dialog that appears, provide the details to justify your action. Then select save_button.png.

    Providing reason for task inactivation
    Figure 5. Providing reason for task inactivation

Once confirmed, the autoexecution task is activated or inactivated. Active tasks start running according to their schedule.

In this section:

An activity in which a monitor, usually a clinical research associate (CRA), visits sites to review and verify study-related activities, including data collection, patient safety, and adherence to the study protocol. The monitor also verifies that the study complies with relevant regulatory requirements and GCP guidelines.

A specific measurement used to monitor and assess potential risks associated with the conduct of the trial. They provide early warning signs of potential issues or deviations that may impact participant safety, data integrity, or the overall success of the study.

Examples of KRIs can be AE report timeliness or query resolution time. The delays in both activities may be considered a sign of the study personnel's neglect. Thus, monitoring is required to ensure the proper conduction of trial activities.